VIC Fellows Spotlight: Secondra Holmes, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...

Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge

Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...

CardioWise Named Quarterfinalists at the UCSF Health Awards

The University of California San Francisco (UCSF) Health Awards has selected CardioWise, Inc. as a Quarterfinalist in the Hospital Diagnostics Category. The awards showcase the health tech industry, showcasing the best...

University Technology Licensing Part 2: Assessing the Opportunities and Negotiating Licenses

Part 2: Technology Transfer and License Terms As was described in Part I of this article [1], VIC has a systematic and thorough technology assessment process. We also have extensive experience negotiating licenses for...

Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform

New company advances novel vaccines to better fight COVID-19 and other pathogens FORT COLLINS, CO - VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc.,...

VIC Fellows Spotlight: Evan Goldberg, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

University Technology Licensing: Assessing the Opportunities and Negotiating Licenses

Part 1: Opportunity Sourcing and Assessment The U.S. invests more than $120 billion in federally sponsored research funding at universities and national labs. Technology Transfer Offices (TTOs) are unique entities...

Tesseract Structural Innovations Receives Two New US and WO Patents

The patents extend Tesseract’s automotive crash energy absorption platform to save lives. The company has received a Notice of Granting and Publication of its second patent “Uniform Deceleration Unit” June 1, 2021 by...

VIC 2021 Mid-Year Update Executive Summary

In the first half of 2021, we have seen a return to more normal operations across VIC and our portfolio of companies. Progress across VIC and our portfolio of companies in 2021 H1 has been strong. Click Here to download...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC adds another esteemed health care veteran to Board. Fayetteville, AR - VIC Technology Venture Development has announced the appointment of Ajay Gupta, who brings 30 years of executive healthcare experience, to its...

Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan

Brad Phelan serves as the Director of Technology Commercialization and Director of Blackstone LaunchPad for UTSW. We recently had a chance to discuss the overall topic of UTSW’s role in the rise of North Texas as the...

Building Life Science Startups Beyond Traditional Venture Capital Hubs

Innovation is Geographically Distributed; Venture Capital Activity is Not The powerful combination of venture capital and innovation is critical to maintaining the global competitiveness of the U.S. While innovation is...

Filtravate Highlighted by New Mexico State University

Filtravate Having licensed a patent-pending technology from New Mexico State University (NMSU), Filtravate went on to refine the technology, building new organic filtration membranes with controlled and tunable pore...

VIC Fellows Spotlight: Michael Gaspar, MD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Zebra Analytix Appoints John A. Michalek as CEO

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that John A. Michalek has joined the company as Chief Executive Officer and Board Member to lead the...

Zero Federal Capital Gains Taxes on High-Return Investments

With a new administration comes new perspectives and likely changes in tax policy. President Biden has proposed doubling the rate that wealthy Americans pay on investment capital gains up to 43.4%, a topic that has been...

Solenic Medical Wins Big at the 2021 Texas A&M New Ventures Competition

Solenic Medical participated in the 2021 Texas A&M New Ventures Competition (TNVC) held live at Texas A&M University after being held virtually in 2020. Twenty-one companies were invited to participate May 19-20 for...

Protecting Early Investors in Capital-Intensive Life Science Companies

Angel investors often invest at the seed stage of a company's development. The typically smaller round sizes and lower valuations allow early individual investors to gain a meaningful stake in a given company. However,...

Behind the Curtain | Single Family Offices and ESG Investing with Brian Cork

Brian Patrick Cork is a principal of brian cork COACHING™, which provides client services in business design, strategy development, executive team-building, and financial capital formation. Please tell us a little about...

VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC adds two life science leaders, bringing additional key insight to the team. VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively...

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

Atkins will bring critical insight into the development and commercialization of inhaled medicines Albuquerque, NM - Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been...

The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World

As discussed in my previous article “Portfolio Diversification During Times of Market Volatility,”[1] one of the few positive outcomes of the worldwide pandemic is the increasing recognition of the power of innovation...

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC Adds Acclaimed Life Science Veteran to Their Team. Fayetteville, AR - VIC Technology Venture Development announced today the appointment of Fenel M. Eloi, a seasoned executive in the life science sector, to their...

Inside CU Innovations: An Interview with Executive Director, Kim Muller

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. We recently had a chance to...

From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. Solenic Medical’s second year was unlike...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that it has been awarded a National Institutes of Health (NIH) Small Business Innovation Research (SBIR)...

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...

VIC 2020 Annual Report Executive Summary

Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Fellows Spotlight: Kirt Gill, MD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Diabeloop SA and SFC Fluidics Announce Development Agreement

SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into...

CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software

CardioWise, Inc., is pleased to announce Clearance of its 510(k) application by the US Food and Drug Administration (FDA) for its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones...

A Letter from our CEO

When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.

FEATURED RESOURCES

Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Insight
Protecting Early Investors in Capital-Intensive Life Science Companies
Interview
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
Updates
VIC 2021 Mid-Year Update Executive Summary
News
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
Interview
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission